Product cited in:
Machuca, Benoit, Nevo et al.: "Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome." in: Journal of the American Society of Nephrology : JASN, Vol. 21, Issue 7, pp. 1209-17, 2010 (PubMed).
Bachas, Schuurhuis, Hollink et al.: "High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicine." in: Blood, Vol. 116, Issue 15, pp. 2752-8, 2010 (PubMed).
Borbulevych, Do, Baker: "Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A*0201: implications for WT1-based cancer therapeutics." in: Molecular immunology, Vol. 47, Issue 15, pp. 2519-24, 2010 (PubMed).
Hollink, van den Heuvel-Eibrink, Zimmermann et al.: "No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 28, pp. e523-6; author reply e527-e528, 2010 (PubMed).
Rocquain, Carbuccia, Trouplin et al.: "Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias." in: BMC cancer, Vol. 10, pp. 401, 2010 (PubMed).